MedPath

Adaptive DBS to Offset STN Dysregulation During Exercise in PD

Recruiting
Conditions
Parkinson Disease
Registration Number
NCT06296810
Lead Sponsor
University of Colorado, Denver
Brief Summary

The investigators conduct a prospective study to evaluate the effects of exercise on Parkinson's Disease brain biomarkers detected with the PerceptTM PC neurostimulator.

Detailed Description

The investigators will conduct a prospective study to evaluate the effects of exercise on Local Field Potential biomarkers detected from the subthalmic nuclues in Parkinson's Disease with the PerceptTM PC neurostimulator. Subsequently, adaptive Deep Brain Stimulation applied in response to low beta peak (L-beta; 13-20Hz) will be performed to evaluate feasibility of whether aDBS can offset the effects of exacerbation of parkinsonism during exercise performance and recovery.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10
Inclusion Criteria

Persons with PD who have a Medtronic DBS Sensight implant and a Percept IPG.

Exclusion Criteria

Persons not meeting the above listed implant criteria Persons not meeting the age limit criteria Persons who are not able to complete the study exercise Persons not able to comprehend and consent to study participation.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
identification of L-beta frequency peak power4 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Colorado

🇺🇸

Aurora, Colorado, United States

University of Colorado
🇺🇸Aurora, Colorado, United States
Pamela David Gerecht, PhD
Contact
303-724-4134
pamela.davidgerecht@cuanschutz.edu
Drew Kern, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.